tirzepatide vs semaglutide head to head In adults with obesity but not diabetes, leads significantly greater weight loss than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL First head-to-head trial compares tirzepatide

Retatrutide titration: 1mg to 12mg The retatrutide titration protocol tested in Phase 3 trials follows a five-step escalation: Weeks 1-4: 1mg weekly Weeks 5-8: 2mg weekly Weeks 9-12: 4mg weekly Weeks 13-16: 8mg weekly Week 17 onward: 12mg weekly (maximum dose) The dose doubles at each step (with the exception of the 1mg to 2mg increase), which is a faster escalation rate than either semaglutide or tirzepatide

Dosage and How Well They Work Knowing how these medications are dosed and how effective they are can help patients and healthcare providers make better treatment decisions

You do not qualify at BMI 25 or 26 under any FDA-approved indication

Powell-Wiley notes, though, that no single drug even a powerful one can fix the many factors that lead to the development of obesity